Topical antifungal treatment cures exit-site fungal infection

Am J Kidney Dis. 2002 Oct;40(4):E15. doi: 10.1053/ajkd.2002.35757.

Abstract

Exit-site fungal infection, although rarely reported, may be a critical complication in patients on peritoneal dialysis. There is no optimal treatment of exit-site fungal infection. We report four cases of exit-site infection with Candida parapsilosis. Four-week treatment with topical sulconazole cream was administered. Fungal infection was cured in all patients but followed by exit-site bacterial infection in two patients. The topical application of sulconazole cream is recommended for exit-site fungal infection.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use
  • Candida / drug effects
  • Candida / isolation & purification
  • Candidiasis / complications
  • Candidiasis / diagnosis
  • Candidiasis / drug therapy*
  • Catheters, Indwelling / adverse effects
  • Catheters, Indwelling / microbiology*
  • Female
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / therapeutic use*
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects

Substances

  • Antifungal Agents
  • Imidazoles
  • sulconazole